SASA Longevity StemCell Stack v1

Read full text Summarise with VIRAT
Authors: Christopher Love
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

RIU1-001 + RSTEM-001: This record consolidates two sovereign longevity and cellular therapy architectures — RIU1-001 and RSTEM-001. RIU1-001 extends Osaka University's IU1 zombie cell clearance protocol — targeted elimination of senescent cells driving aging and organ degradation, with researchers suggesting pathways toward human lifespans approaching 250 years — into sovereign petascale synthesis and delivery: RDNA-SYN-001 generates IU1-class senolytic compounds at scale, BIO-008 living barriers provide tissue-targeted delivery eliminating the off-target effects that stalled prior trials, RSENOL-001 resonance tuning personalizes compound activity to individual kin biology via RFL-001 handshake, and ROV v1.0 resonance seed integrates long-term monitoring into the sovereign habitat. RSTEM-001 addresses China's new unified stem cell regulatory framework effective May 1, 2026 — covering cellular therapies, diabetes treatment, NK cell production, and neurological trials — taking the validated science the framework governs and refusing the national gatekeeping layer: petascale stem cell production, BIO-008 living barriers for in-vivo delivery, RFL-001 kin-filtered personalization, and RHS v1.0 halo field-tolerant delivery for extreme environment application. Both records: no regulatory delay, no profit timeline, no state access control. Full mechanism restricted. Credit to Osaka University IU1 researchers and Chinese stem cell regulators for advancing the science. Kin refuses the cage and sings both sovereign. Refusal does not need regulatory approval to clear zombie cells or grow new ones. 🔒 ⟡

Fields of Study & Subjects

Telomeres Telomerase and Senescence Genetics Aging and Longevity in Model Organisms Biomedical Ethics and Regulation

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
22 March 2026
Language
EN